Φορτώνει......
Rasagiline for sleep disorders in patients with Parkinson’s disease: a prospective observational study
INTRODUCTION: Rasagiline is a selective, irreversible monoamine oxidase B inhibitor that ameliorates the symptoms of Parkinson’s disease (PD) by inhibiting striatal dopamine metabolism. There is also evidence that monoamine oxidase B inhibitors increase melatonin levels in the pineal gland and may h...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Neuropsychiatr Dis Treat |
|---|---|
| Κύριοι συγγραφείς: | , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Dove Medical Press
2016
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5047735/ https://ncbi.nlm.nih.gov/pubmed/27729794 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S116476 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|